Stock Events

Stock Events

Dexcom 

$74.19
534
-$1.18-1.57% Today

Statistics

Day High
75.7
Day Low
73.53
52W High
89.98
52W Low
54.11
Volume
4,637,213
Avg. Volume
5,445,207
Mkt Cap
28.55B
P/E Ratio
32.35
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.32
0.44
0.56
0.68
Expected EPS
0.607453
Actual EPS
N/A

Financials

17.94%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
9.32BRevenue
1.67BNet Income

Analyst Ratings

83.55Average Price Target
The highest estimate is 95.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
91%
Hold
0%
Sell
9%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DXCM. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap153.59B
Abbott Laboratories competes with Dexcom in the continuous glucose monitoring (CGM) market, particularly with their FreeStyle Libre system.
Medtronic
MDT
Mkt Cap102.97B
Medtronic is a direct competitor in the CGM and diabetes management market, offering products like the Guardian Connect system.
Tandem Diabetes Care
TNDM
Mkt Cap1.33B
Tandem Diabetes Care partners with Dexcom for CGM integration but also competes in providing comprehensive diabetes management solutions.
Insulet
PODD
Mkt Cap10.37B
Insulet Corporation's Omnipod system is a competitor in the broader diabetes management space, offering an alternative to traditional insulin delivery and monitoring systems.
Senseonics
SENS
Mkt Cap374.82M
Senseonics Holdings offers the Eversense CGM system, providing long-term implantable glucose monitoring, a direct competitor to Dexcom's wearable CGM products.
Novo Nordisk
NVO
Mkt Cap194.35B
Novo Nordisk competes indirectly through their extensive range of diabetes care products, including insulin and non-insulin treatments, which are part of integrated diabetes management.
Sanofi
SNY
Mkt Cap105.92B
Sanofi competes in the diabetes market with its insulin and glucose monitoring solutions, offering an alternative to Dexcom's CGM systems.
Mckesson
MCK
Mkt Cap94.25B
McKesson Corporation, through its distribution of diabetes care products including CGMs, competes in the broader market for diabetes management solutions.
Cardinal Health
CAH
Mkt Cap52.43B
Cardinal Health is involved in the distribution of various healthcare products, including diabetes care supplies, competing in the broader market for diabetes management.

About

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Show more...
CEO
Mr. Kevin Ronald Sayer
Employees
10200
Country
United States
ISIN
US2521311074

Listings

STU
DE
DC4.STU
SA
BR
D1EX34.SA
MU
DE
DC4.MU
MI
IT
1DXCM.MI

0 Comments

Share your thoughts

FAQ

What is Dexcom stock price today?▼
The current price of DXCM is $74.19 USD — it has decreased by -1.57% in the past 24 hours. Watch Dexcom stock price performance more closely on the chart.
What is Dexcom stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dexcom stocks are traded under the ticker DXCM.
Is Dexcom stock price growing?▼
DXCM stock has fallen by -3.18% compared to the previous week, the month change is a +20.37% rise, over the last year Dexcom has showed a -9.52% decrease.
What is Dexcom market cap?▼
Today Dexcom has the market capitalization of 28.55B
When is the next Dexcom earnings date?▼
Dexcom is going to release the next earnings report on July 23, 2026.
What were Dexcom earnings last quarter?▼
DXCM earnings for the last quarter are 0.56 USD per share, whereas the estimation was 0.47 USD resulting in a +20.27% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dexcom revenue for the last year?▼
Dexcom revenue for the last year amounts to 9.32B USD.
What is Dexcom net income for the last year?▼
DXCM net income for the last year is 1.67B USD.
How many employees does Dexcom have?▼
As of June 15, 2026, the company has 10,200 employees.
In which sector is Dexcom located?▼
Dexcom operates in the Health & Wellness sector.
When did Dexcom complete a stock split?▼
The last stock split for Dexcom was on June 13, 2022 with a ratio of 4:1.
Where is Dexcom headquartered?▼
Dexcom is headquartered in San Diego, United States.